戻る
Bright Minds Biosciences Inc (DRUG)価格
DRUG 株価推移チャート
DRUG 収入
Bright Minds Biosciences Inc
$88
-2.12%
$-1.9
終値： Jan 16, 16:00:00 GMT-5
$89.74
1.97%
$1.73
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$89.91
始値
$89.59
当日レンジ
$86.39 - $89.74
52週レンジ
$23.17 - $123.75
取引高
111.4K
平均取引高
209.4K
1株当たり利益(TTM)
-1.30
配当利回り
--
時価総額
$698.8M
DRUGとは何ですか？
Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company is headquartered in New York City, New York and currently employs 0 full-time employees. The company went IPO on 2021-02-08. The firm is focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and other central nervous system (CNS) disorders. Its Serotonin (5-HT) is a neurotransmitter in the brain and modulates many biological functions. Dysfunction of serotonin receptors, transporters, and associated neurocircuits is fundamental to many diseases including epilepsies and neuro psychiatric. Its pipeline includes BMB-101, BMB-xxx, BMB-201, and BMB-202. The firm has a portfolio of patented, selective serotonin (5-HT2C, 5-HT2A and 5-HT2C/A-receptor subtypes) agonists that were identified by using high-throughput screening methods in combination with advanced molecular modeling techniques to interrogate the interaction between the drug and its targeted receptors to increase downstream signaling.